Breast Cancer Treatment: Complete Clinical Guide, Benefits & Recovery

Clinical Overview: Understanding Breast Cancer Treatment

Breast Cancer Treatment represents a cornerstone clinical program at Spica Healthcare — Grover Hospital, Bathinda. Supervised directly by Dr. Neha Gupta (Director & Senior Medical Oncologist), this evidence-based pathway integrates sub-millimeter surgical precision, advanced intraoperative 3D navigation, ISO Class-100 Laminar Airflow surgical suites, and personalized accelerated rehabilitation to restore function, eliminate pain, and maximize long-term treatment longevity.

In South-Western Punjab and adjoining regions of Haryana and Rajasthan, patients frequently encounter delayed clinical diagnoses or generalized approaches that fail to address anatomical nuances. At Spica Healthcare, every patient undergoes rigorous digital staging, ensuring that surgical interventions or targeted medical therapies are customized to individual biomechanics and oncological requirements.

Clinical Indications: When is Breast Cancer Treatment Recommended?

• Newly diagnosed invasive ductal, lobular, or inflammatory breast carcinoma of any clinical stage (Stage 1 to 4).

• Triple-Negative Breast Cancer (TNBC) requiring neoadjuvant chemotherapy + Pembrolizumab immunotherapy.

• HER2-positive early breast cancer requiring neoadjuvant targeted dual blockade (Trastuzumab + Pertuzumab).

• Hormone-receptor-positive breast cancer requiring precision genomic testing (Oncotype DX) and endocrine therapy.

Step-by-Step Surgical & Clinical Pathway at Grover Hospital

Step 1: Biomarker Profiling & PET-CT Staging

Core biopsy re-evaluation of ER, PR, HER2, Ki-67, and whole-body FDG PET-CT staging scan.

Step 2: Neoadjuvant Systemic Oncology

Neoadjuvant systemic chemotherapy, targeted therapy, or immunotherapy in Day Care Infusion Suite.

Step 3: Definitive Surgical Resection

Breast-conserving oncoplastic surgery or skin-sparing mastectomy with sentinel lymph node biopsy.

Step 4: Adjuvant Radiation & Maintenance

Adjuvant radiation therapy and 5-to-10 year oral endocrine/targeted maintenance schedule.

Director's Signature Innovation: Comprehensive Multimodal Breast Cancer Oncology

Dr. Neha Gupta coordinates comprehensive multidisciplinary breast cancer treatment at Spica Healthcare. Integrating molecular subtyping (Luminal A, Luminal B, HER2-enriched, Triple-Negative Breast Cancer - TNBC), neoadjuvant dose-dense chemotherapy with scalp cooling for hair preservation, targeted anti-HER2 antibodies (Trastuzumab/Pertuzumab), Keynote-522 immunotherapy for TNBC, breast-conserving surgery with sentinel lymph node biopsy, and precision radiotherapy, over 95% of early breast cancer patients achieve complete long-term cure.

✔ Molecular Subtype-Driven Care: Customizes chemotherapy, targeted drugs, or immunotherapy for each subtype

✔ Keynote-522 Protocol for TNBC: Combines Pembrolizumab immunotherapy with chemotherapy for high pCR rates

✔ Breast-Conserving & Sentinel Node Care: Spares healthy axillary lymph nodes to prevent painful lymphedema

✔ Scalp Cooling Hair Protection: Advanced automated scalp-cooling caps significantly reducing hair loss

Recovery Timeline & Functional Milestones

Phase 1: Diagnostic Staging & Access (Day 1 – 7)

Comprehensive staging (PET-CT/Mammogram), IHC biomarker verification, and Chemoport placement.

Phase 2: Neoadjuvant Systemic Phase (Month 1 – 4)

Neoadjuvant chemotherapy/targeted therapy in Daycare suite with scalp cooling and anti-emetic care.

Phase 3: Definitive Local Therapy (Month 5 – 6)

Breast-conserving surgery or mastectomy followed by adjuvant radiotherapy.

Phase 4: Survivorship & Remission (Month 6 – Long Term)

Adjuvant targeted/endocrine maintenance therapy and long-term survivorship surveillance.

Frequently Asked Clinical Questions (FAQs)

Why is molecular subtyping so important in breast cancer treatment?

Breast cancer is classified into 4 biological subtypes: ER+/PR+ (hormone responsive), HER2+ (requires targeted anti-HER2 therapy), and Triple-Negative (requires chemotherapy + immunotherapy). Identifying the exact subtype from your biopsy allows Dr. Neha Gupta to tailor the most effective treatment.

Can early breast cancer be cured without removing the whole breast?

Yes! Today, most women with breast cancer can safely undergo Breast-Conserving Surgery (lumpectomy) combined with sentinel lymph node biopsy and radiation, which cures the cancer just as effectively as removing the whole breast (mastectomy) while keeping your natural breast intact.

Is Breast Cancer Treatment cashless under Ayushman Bharat?

Yes, comprehensive breast cancer treatments, neoadjuvant/adjuvant chemotherapy, targeted biologics, and inpatient surgeries at Grover Hospital Bathinda are covered 100% cashless under PM-JAY Ayushman Bharat and 30+ private TPAs.

100% Cashless Insurance & PM-JAY Ayushman Bharat Empanelment

At Spica Healthcare — Grover Hospital Bathinda, Breast Cancer Treatment is fully covered under the Government of India's PM-JAY Ayushman Bharat scheme and over 30+ leading private insurance TPAs. Our on-campus insurance coordinator handles all pre-authorization documentation directly with your insurance company, eliminating financial delays. Families can also share digital DICOM CDs and biopsy reports via WhatsApp (+91 95013 73003) for an urgent surgical review.